At a glance
The March 30, 2020, Clinical Laboratory COVID-19 Response (CLCR) call included updates on serology testing, emergency use authorizations, CLIA guidance, surveillance, and biosafety.
Agenda
Archived LOCS Materials Access
Welcome and Introductions: Jasmine Chaitram, CDC Division of Laboratory Systems
Serology Testing, Updated Testing Guidance, Nasal Swabs: Wendi Kuhnert-Tallman, CDC Laboratory Task Force
Emergency Use Authorizations (EUAs) for Serology Tests and At-Home/Self-Collection Tests: Tim Stenzel, U.S. Food and Drug Administration (FDA)
New CLIA Guidance and Validating Tests for Laboratories Responding to COVID-19: Karen Dyer, Centers for Medicare & Medicaid Services (CMS)
Supporting Epidemiologic and Surveillance Needs: Janet Hamilton, Council of State and Territorial Epidemiologists (CSTE)
Laboratory Biosafety Update: Bill Arndt, CDC Division of Laboratory Systems
This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.
The information on this page was last reviewed by subject matter experts to ensure accuracy.